Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells

Male STAT3 Transcription Factor Quantitative Trait Loci T cells Receptor, Transforming Growth Factor-beta Type I 610 Medicine & health Protein Serine-Threonine Kinases STAT3 03 medical and health sciences Humans 3205 Medicina interna 2403 Immunology 0303 health sciences Interleukin-17 IL12RB1 Genetic Diseases, Inborn Receptor, Transforming Growth Factor-beta Type II Receptors, Interleukin-12 Cell Differentiation T-Lymphocytes, Helper-Inducer 3. Good health Interleukin-1 Receptor-Associated Kinases 10036 Medical Clinic Mutation Myeloid Differentiation Factor 88 2723 Immunology and Allergy Brief Definitive Reports Cytokines Female 32 Ciencias médicas Receptors, Transforming Growth Factor beta Signal Transduction
DOI: 10.1084/jem.20080321 Publication Date: 2008-07-01T23:56:29Z
ABSTRACT
The cytokines controlling the development of human interleukin (IL) 17–producing T helper cells in vitro have been difficult to identify. We addressed question IL-17–producing vivo by quantifying production and secretion IL-17 fresh ex vivo, cell blasts expanded from patients with particular genetic traits affecting transforming growth factor (TGF) β, IL-1, IL-6, or IL-23 responses. Activating mutations TGFB1, TGFBR1, TGFBR2 (Camurati-Engelmann disease Marfan-like syndromes) loss-of-function IRAK4 MYD88 (Mendelian predisposition pyogenic bacterial infections) had no detectable impact. In contrast, dominant-negative STAT3 (autosomal-dominant hyperimmunoglobulin E syndrome) and, a lesser extent, null IL12B IL12RB1 susceptibility mycobacterial diseases) impaired cells. These data suggest that IL-12Rβ1– STAT-3–dependent signals play key role differentiation and/or expansion populations vivo.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (384)